Timor Arbel-Sadras

Role

Growth-stage VC investor (“I’m a numbers person — I get excited by a business whose numbers work really, really well”); advisory source for the insurance direction. Fund affiliation (unknown — needs source), but the intro chain (Guy’s father + Tomer recommended her; she casually references Eran) and shared portfolio language suggest proximity to brm’s circle — verify before asserting.

Affiliations

  • antidote — investor (“we invested”).
  • faye — ran/participated in diligence (brought advisers to attack the “too good to be true” unit economics); speaks with insider detail on strategy and metrics.
  • guardz — refers to it as “my company” (cyber for SMBs; likely board/portfolio involvement — exact role unverified).

Notes

  • Self-declared not an insurance specialist — cyber is her home turf — but believes AI “flatters” insurance: like banking but further behind, still run by “old gorillas” on untouchable legacy systems, so AI-native entrants are structurally advantaged.
  • Ideation doctrine: start from a very large unsolved pain; be 10x better, not incrementally better, or an old-school market won’t transform.
  • Two insurtech pain archetypes she uses: future pain you see before incumbents (at-bay cyber underwriting) vs. existing market failure (antidote in US health).
  • On carriers: “like a supermarket, ~3%” margins — topline inflates fast, unit economics brutally hard.
  • On brokers: old-fashioned, slow, non-technological — only a market-breaking pain reliever (e.g., halving office headcount) gets adopted.
  • On Israeli founders: starting in Israel is a recurring trap (passportcard vs faye); early local customers drag the company and it gets stuck.
  • Open invitation for the team to return at a more advanced stage.

Mentioned in